Expect Equity LLC Purchases New Shares in HealthEquity, Inc. $HQY

Expect Equity LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 24,200 shares of the company’s stock, valued at approximately $2,186,000.

A number of other institutional investors have also added to or reduced their stakes in HQY. Acumen Wealth Advisors LLC purchased a new stake in HealthEquity in the 4th quarter valued at about $27,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity in the 4th quarter worth approximately $28,000. Leonteq Securities AG grew its holdings in shares of HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC bought a new position in shares of HealthEquity in the first quarter valued at approximately $33,000. 99.55% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Citizens Jmp upped their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday, June 1st. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research report on Monday, June 1st. Barrington Research reaffirmed an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Finally, Royal Bank Of Canada lifted their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Eleven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the company’s stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the sale, the executive vice president directly owned 52,244 shares of the company’s stock, valued at $4,963,180. This represents a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. The trade was a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 17,905 shares of company stock worth $1,651,280. Company insiders own 1.60% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $105.39 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The business has a fifty day simple moving average of $97.41 and a two-hundred day simple moving average of $87.53. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $107.62. The company has a market capitalization of $8.81 billion, a P/E ratio of 39.47, a P/E/G ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.